Glucose metabolism outcomes after pituitary surgery in patients with acromegaly.
Eider Pascual-CorralesBetina BiagettiMónica MarazuelaDiego Asensio-WandoselVíctor Rodríguez BerrocalAna Irigaray EcharriCristina Novo-RodríguezMaría CalatayudIgnacio BernabéuCristina Alvarez-EscolaCarmen Tenorio-JiménezInmaculada González MoleroPedro IglesiasConcepción BlancoPaz de MiguelElena López MezquitaCristina LamasAnna AulinasPaola GraciaJosé María Recio-CórdovaMiguel Sampedro-NuñezMiguel PajaMaría Dolores Moure RodríguezCarmen Fajardo-MontañanaFernando CordidoEdelmiro Menéndez TorreJuan Carlos PercovichRogelio García-CentenoRosa CámaraFelicia Alexandra HanzuAlmudena Vicente DelgadoLaura González FernándezFernando Guerrero-PérezMaría Dolores Ollero García-AgullóIría Novoa-TestaRocío Villar-TaiboPamela Benítez ValderramaPablo Abellán GalianaEva Venegas MorenoFernando Vidal-Ostos De LaraJoaquim EnseñatSilvia AznarQueralt AslaMaría Dolores Aviles-PérezManel Puig-DomingoMarta Araujo-CastroPublished in: Pituitary (2024)
Glucose metabolism improved in patients with acromegaly after surgery and 21% of the diabetic patients experienced diabetes remission; being more frequent in patients of older age, and those who experienced surgical cure and those with preserved anterior pituitary function after surgery.
Keyphrases
- growth hormone
- end stage renal disease
- type diabetes
- newly diagnosed
- ejection fraction
- chronic kidney disease
- minimally invasive
- cardiovascular disease
- physical activity
- prognostic factors
- peritoneal dialysis
- coronary artery bypass
- patient reported outcomes
- systemic lupus erythematosus
- disease activity
- middle aged
- rheumatoid arthritis
- skeletal muscle
- insulin resistance
- weight loss